Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Dohil R, Newbury RO, Sellers ZM, Deutsch R, Schneider JA (2003) The evaluation and treatment of gastrointestinal disease in children with cystinosis receiving cysteamine
Why do some oral KPV formulations fail to produce effects seen in published studies
Updated Results of CPX-351 in Combination with Gemtuzumab Ozogamicin (GO) in Relapsed Refractory (R/R) Acute Myeloid Leukemia (AML) and Post-Hypomethylating Agent (Post-HMA) Failure High-Risk Myelodysplastic Syndrome (HR-MDS)
The monthly premium beneficiaries pay for Medicare Part B rose significantly, from $148.50 to $170.10 per month in 2022
For example, ensure that the medium being used for serum-free culture is actually designed for serum-free culture
US$ 22.82
US$ 21.44
US$ 20.62
US$ 22.98
US$ 21.03
US$ 24.04
US$ 23.92
